CNTY-813 is an iPSC-derived islet cell replacement therapy engineered with Allo-Evasion™ 5.0 for patients with type 1 diabetes; on track for IND submission in 4Q 2026 ...
Investors are weighing Pfizer’s stable dividend and oncology-focused growth strategy against the higher-risk, higher-reward potential of biotech firms. Pfizer is navigating a post-COVID revenue ...
Nuvalent is positioned as a high-quality late-stage biotech with two near-commercial precision oncology assets. Read more on ...
ASBP Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is attempting something relatively uncommon in the biotech space: ...
Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the small-cap stocks that are on fire right now. On April 16, Spyre ...
CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ® (pertuzumab) 420 mg/14 mL injection for ...
GeoVax CEO David Dodd highlights the need for U.S. manufacturing to reduce reliance on foreign biotech and strengthen ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
Carbios (Euronext Growth Paris: ALCRB) announces to its shareholders and the financial community that its 2025 Universal Registration Document, including: the 2025 annual report, comprising the ...
Globevisa analyzes how Dominica's 33-year CBI program provides HNWIs with constitutional reliability and economic ...
Laguna Biotherapeutics, Inc. (Laguna), a clinical-stage biotechnology company focused on novel live bacterial therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results